Previous Close | 22.88 |
1-Year Change | -41.45% |
6-Months Change | -16.92% |
3-Months Change | 6.17% |
Moving Avg (50d) | 19.543 |
Moving Avg (200d) | 27.804 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.82B |
Beta (3-Years) | 0.92 |
Revenue Growth (ttm) | -1.44% |
Net Profit Margin (ttm) | 6.54% |
Return On Assets (ttm) | 2.7% |
EPS (ttm) | 1.21 |
PE Ratio (ttm) | 18.91 |
Dividend Yield | % |
Asset Description: | Integra LifeSciences Holdings Corporation |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-11-11 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
23.389 | 24.077 | 24.535 | 25.223 | 26.37 | 27.516 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.